Project SCOPE: Supporting Children of the OPioid Epidemic


The goal of Project SCOPE Vermont is to help providers develop effective screening, monitoring, and interdisciplinary support for children and families with Neonatal Abstinence Syndrome. 

Neonatal Abstinence Syndrome, or NAS, is a medical condition in infants who go into opioid withdrawal shortly after they're born.

Learn More About Project SCOPE
Learning Session Materials


Why Project SCOPE Vermont?

The CDCI is receiving support from the Wyoming Institute for Disabilities (WIND) to improve training & supports for children and families with Neonatal Abstinence Syndrome (NAS). The work is called Project SCOPE: Supporting Children of the OPioid Epidemic.

Vermont has one of the highest rates of NAS in the U.S. And for 20 years, Vermont has worked to decrease barriers for pregnant people to receive addiction treatment. A key initiative working on this is Project ICON (Improving Care for Opioid-Exposed Newborns) at the UVM Larner College of Medicine.


This project is supported in part by grant number 90DDUC0062, from the U.S. Administration for Community Living, Department of Health and Human Services, Washington, D.C. 20201.​​ Grantees undertaking projects with government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official ACL policy.​




If you have questions about Project SCOPE Vermont, please send an email to

This program was offered at no cost to participants through a collaboration between the Center on Disability and Community Inclusion, Vermont Child Health Improvement Program, Wyoming Institute for Disabilities, and the Vermont Department of Health.





Family Image by Clip Art